Cubist Systematic Strategies LLC Takes $585,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Cubist Systematic Strategies LLC acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 44,042 shares of the company’s stock, valued at approximately $585,000. Cubist Systematic Strategies LLC owned 0.11% of Phibro Animal Health at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Brandes Investment Partners LP grew its position in shares of Phibro Animal Health by 94.0% in the 3rd quarter. Brandes Investment Partners LP now owns 198,820 shares of the company’s stock valued at $2,642,000 after acquiring an additional 96,317 shares during the period. WINTON GROUP Ltd boosted its holdings in shares of Phibro Animal Health by 21.7% during the 3rd quarter. WINTON GROUP Ltd now owns 21,153 shares of the company’s stock worth $281,000 after buying an additional 3,765 shares during the period. ExodusPoint Capital Management LP bought a new stake in shares of Phibro Animal Health during the 3rd quarter worth about $333,000. Tower Research Capital LLC TRC boosted its holdings in Phibro Animal Health by 430.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,378 shares of the company’s stock valued at $71,000 after purchasing an additional 4,364 shares during the period. Finally, UBS Group AG boosted its holdings in Phibro Animal Health by 3,713.7% in the 3rd quarter. UBS Group AG now owns 4,462 shares of the company’s stock valued at $59,000 after purchasing an additional 4,345 shares during the period. Institutional investors own 49.21% of the company’s stock.

Phibro Animal Health Price Performance

PAHC stock opened at $15.29 on Monday. The company has a 50 day simple moving average of $15.36 and a 200 day simple moving average of $14.29. The stock has a market cap of $619.31 million, a price-to-earnings ratio of 16.99, a P/E/G ratio of 8.19 and a beta of 0.60. Phibro Animal Health Co. has a 1 year low of $11.75 and a 1 year high of $20.68. The company has a debt-to-equity ratio of 1.72, a current ratio of 3.47 and a quick ratio of 1.75.

Phibro Animal Health (NASDAQ:PAHC – Get Rating) last released its quarterly earnings data on Wednesday, February 8th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.04. The business had revenue of $244.60 million during the quarter, compared to analysts’ expectations of $238.44 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 18.90%. Research analysts anticipate that Phibro Animal Health Co. will post 1.25 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 22nd. Shareholders of record on Wednesday, March 1st will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 3.14%. The ex-dividend date is Tuesday, February 28th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 53.33%.

Wall Street Analyst Weigh In

PAHC has been the subject of several analyst reports. Roth Capital initiated coverage on shares of Phibro Animal Health in a research report on Wednesday, December 21st. They issued a “buy” rating and a $18.00 target price for the company. Morgan Stanley dropped their target price on shares of Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Thursday, February 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $18.00.

About Phibro Animal Health

(Get Rating)

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.